Dextrothyroxine: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Protected "Dextrothyroxine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(One intermediate revision by one other user not shown)
Line 53: Line 53:


==Overview==
==Overview==
'''Dextrothyroxine''' (trade name '''Choloxin''') saw research as an cholesterol-lowering drug<ref>{{cite pmid|6475988}}</ref><ref>{{cite pmid|9440092}}</ref> but was pulled due to cardiac side-effects. It also increases [[hepatic lipase]] which in turn improves utilization of triglycerides, improving [[apolipoprotein E]] cholesterol particles.{{fact|date=March 2012}}
'''Dextrothyroxine''' (trade name '''Choloxin''') saw research as an cholesterol-lowering drug but was pulled due to cardiac side-effects. It also increases [[hepatic lipase]] which in turn improves utilization of triglycerides, improving [[apolipoprotein E]] cholesterol particles.


==See Also==
==See Also==

Latest revision as of 19:49, 18 August 2015

Dextrothyroxine
Clinical data
Trade namesCholoxin
SynonymsD-3,5,3',5'-tetraiodothyronine
AHFS/Drugs.comMultum Consumer Information
Pregnancy
category
  • US: B (No risk in non-human studies)
ATC code
Legal status
Legal status
  • Discontinued
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H11I4NO4
Molar mass776.87 g/mol
3D model (JSmol)

WikiDoc Resources for Dextrothyroxine

Articles

Most recent articles on Dextrothyroxine

Most cited articles on Dextrothyroxine

Review articles on Dextrothyroxine

Articles on Dextrothyroxine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dextrothyroxine

Images of Dextrothyroxine

Photos of Dextrothyroxine

Podcasts & MP3s on Dextrothyroxine

Videos on Dextrothyroxine

Evidence Based Medicine

Cochrane Collaboration on Dextrothyroxine

Bandolier on Dextrothyroxine

TRIP on Dextrothyroxine

Clinical Trials

Ongoing Trials on Dextrothyroxine at Clinical Trials.gov

Trial results on Dextrothyroxine

Clinical Trials on Dextrothyroxine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dextrothyroxine

NICE Guidance on Dextrothyroxine

NHS PRODIGY Guidance

FDA on Dextrothyroxine

CDC on Dextrothyroxine

Books

Books on Dextrothyroxine

News

Dextrothyroxine in the news

Be alerted to news on Dextrothyroxine

News trends on Dextrothyroxine

Commentary

Blogs on Dextrothyroxine

Definitions

Definitions of Dextrothyroxine

Patient Resources / Community

Patient resources on Dextrothyroxine

Discussion groups on Dextrothyroxine

Patient Handouts on Dextrothyroxine

Directions to Hospitals Treating Dextrothyroxine

Risk calculators and risk factors for Dextrothyroxine

Healthcare Provider Resources

Symptoms of Dextrothyroxine

Causes & Risk Factors for Dextrothyroxine

Diagnostic studies for Dextrothyroxine

Treatment of Dextrothyroxine

Continuing Medical Education (CME)

CME Programs on Dextrothyroxine

International

Dextrothyroxine en Espanol

Dextrothyroxine en Francais

Business

Dextrothyroxine in the Marketplace

Patents on Dextrothyroxine

Experimental / Informatics

List of terms related to Dextrothyroxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dextrothyroxine (trade name Choloxin) saw research as an cholesterol-lowering drug but was pulled due to cardiac side-effects. It also increases hepatic lipase which in turn improves utilization of triglycerides, improving apolipoprotein E cholesterol particles.

See Also

References

Template:Lipid modifying agents